SPONSORS & EXHIBITORS
Raise your company’s profile and get in front of the brightest healthcare AI brains, spanning the whole global ecosystem of pharmaceutical, biotech, medtech, clinicians and healthcare providers, health tech companies, insurers, academics and investors.
A good way to work out what will give you the most cost-effective impact is to talk to us.
Get started today, download the sales pack
HEADLINE SPONSOR 2018
Novartis is a leading global medicines company based in Basel, Switzerland, with a history going back more than 150 years. We use innovative science, digital technology and new business models to address the evolving needs of patients and societies worldwide. Novartis products are available in about 155 countries and they reached nearly 1 billion people globally in 2017. About 120 000 people of more than 140 nationalities work at Novartis around the world.
Want to get involved? Contact us today to discuss partnership opportunities
Fondation Botnar is a charitable foundation based in Basel (Switzerland). They are joining world summit AI to promote the importance of AI for child wellbeing and health. The foundation will host a workshop to discuss the latest ways for artifical intelligence and the mining of big data to support and enhance children’s access to health and related services.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes care.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.
Accenture’s Life Sciences group is committed to helping our clients make a meaningful impact on patients’ lives by combining new science with leading-edge technology to revolutionize how medical treatments are discovered, developed and delivered to people around the world. We provide end-to-end business services as well as individual strategy, consulting, digital, technology and operations projects around the globe in all strategic and functional areas—with a strong focus on R&D, Sales & Marketing, Patient Services and the Supply Chain. We have decades of experiences working with the world’s most successful companies to innovate and improve their performance across the entire Life Sciences value chain. Accenture’s Life Sciences group connects more than 15,000 skilled professionals in over 50 countries who are personally committed to helping our clients achieve their business objectives and deliver better health and economic outcomes.
Basel lies at the heart of the three-country-triangle where Switzerland, France and Germany meet. Cross-border relations have always been a part of life here. Basel collaborates closely with its neighbours on all sides of the borders on issues such as transport, environment, education and culture. Basel is the most dynamic business location in Switzerland and one of the most productive worldwide. Global players such as Novartis and Roche are based in Basel and the surrounding region. But many other companies as well from the researchoriented areas of life sciences, chemistry and nanotechnology are powerful drivers of innovation.
Umana Medical Technologies offers innovative clinical-grade solutions for long-term monitoring of physiological parameters.
Umana T1 leverages on its Tattoo nanomaterial sensors to seamlessly collect vital signs data, providing cardiac professionals with important medical data without interfering with the patients
day to day activities. This is complemented with an eco-system of clinical grade software, hardware and artificial neural algorithms that ensures the highest quality and reliability of data gathered and analysed, helping the medical professional make better informed decisions when diagnosing and selecting treatment.
QuantumBlack is an advanced analytics firm operating at the intersection of strategy, technology and design to improve performance outcomes for organisations.
In 2015 we became part of McKinsey & Company. Together we combine our advanced analytics, design and engineering expertise with McKinsey’s industry expertise and organisational change management experience.
QuantumBlack was born and proven in Formula 1 – where teams live and breathe data. Today, we are still fascinated by how a marginal gain can have a significant impact on the performance of any organisation.
FRONTIERS MEDIA SA
Frontiers in Big Data and Frontiers in Artificial Intelligence publish rigorously peer-reviewed research on the cutting-edge, disruptive technological revolution of Big Data and Artificial Intelligence (AI). The journals publish a broad range of topics in Big Data and AI, and their various applications. As key interdisciplinary open-access journals, we are at the forefront of disseminating scientific knowledge and impactful discoveries to academics, policy-makers, industry, and the public worldwide.
Sections focus on AI and Big Data in relation to Medicine and Health, Cybersecurity and Privacy, Data Mining, Climate Sciences, Machine Learning, Fuzzy Systems, Natural Language Processing, LegalTech, and AI in Finance.
With a track-record of 20+ years in machine learning and artificial intelligence, Balzano builds solutions for healthcare that leverage modern cognitive science and deep learning. With a team of seasoned data scientists and engineers based in Zurich, Switzerland, and a sister-company in the United States (Tampa, FL), Balzano focuses on the interpretation and quantitative analysis of unstructured data, such as clinical MRI scans (detecting MSK pathologies, quantifying body composition from Dixon scans, etc.) or medical reports (generating ICD, CHOP and other billing codes through semantic understanding of treatment reports).
Know Your Meds
KnowYourMeds is a new, AI based mobile application available on iOS and Android devices. The app provides users with proactive, profile-based information on all the medications you (and your loved ones) are taking. Information consists of dosage instructions, regulatory warnings, drug interactions, reported side and adverse effects as well as interactions with food and drinks. The app provides smart pill reminder features to ensure that you and your dependents never miss a dose, as well as prescription refills.
Advanced users will also have access to the latest world-wide articles and peer reviewed medical papers on medications and disease conditions.
Skychain is a blockchain infrastructure aimed to train, host and use neural networks for medical diagnostics. Medical malpractices are the third leading cause of death. We are confident that by introducing the perspective of artificial intelligence into medical diagnostics we can save millions of lives. But what makes the project unique? We are creating a digital space, which will unite the key players of the market: medical data providers, AI developers, providers of computational powers and millions of consumers all over the world.
Medicus is an AI-based platform that explains and interprets medical reports and health data, turning numbers into meaningful insights.
Medicus works with healthcare companies to deliver smart features & insights to both doctors – in terms of smart testing & diagnosis support – and to patients in the form of visual & interactive reports, powering continuous healthcare & coaching across all digital platforms.
Medicus is based in Vienna with offices in Berlin, Paris & Beirut.
dacadoo is a global technology company that is driving the digital transformation in healthcare. Based in Zurich, Switzerland, dacadoo strengthens health and wellbeing through active engagement and artificial intelligence. dacadoo develops and operates a mobile-first digital health engagement platform that helps people live healthier, more active lives through a combination of motivational techniques from behavioral science, online gaming and social networks, as well as artificial intelligence and automated coaching. Based on over 300 million person-years of clinical data, its patented, real-time Health Score makes health individually measurable, which provides users with a unique engagement experience, while also offering dacadoo’s enterprise customers an effective way to measure the true health impact of wellness programs. Available in over 10 languages, dacadoo’s technology is provided as a fully branded, white-label solution or it can be integrated into customer products through its API. dacadoo’s customers include health and life insurance companies, health & wellness service organizations as well as large and mid-sized employers for health promotion in the workplace.
The ITU-T Focus Group on Artificial Intelligence for Health (AI4H) was established by ITU-T Study Group 16 at its meeting in Ljubljana, 9-20 July 2018. The Focus Group will work towards a standardized assessment of AI4H solutions, in partnership with the World Health Organization.
Participation in the FG-AI4H is free of charge and open to all.